JVM Co

JVM Co EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of JVM Co (054950.KQ) as of Nov 4, 2026 is 9.05. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was 6.94 — a change of 30.46% (higher).

EV/EBITDA

9.05

YoY

30.46%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of JVM Co is 2025 9.05 . EV/EBITDA (Enterprise Value to EBITDA) of JVM Co was 2024 6.94 . It decreases by 30.46% higher compared to the previous year.

The JVM Co EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
27.60 KRW
Jan 1, 2019
35.83 KRW
Jan 1, 2020
19.84 KRW
Jan 1, 2021
20.81 KRW
Jan 1, 2022
12.06 KRW
Jan 1, 2023
7.69 KRW
Jan 1, 2024
6.94 KRW
Jan 1, 2025
9.05 KRW
The JVM Co EV/EBITDA history
YEAREV/EBITDAYoY
9.05+30.46%
6.94-9.77%
7.69-36.25%
12.06-42.05%
20.81+4.90%
19.84-44.63%
35.83+29.84%
27.60+22.12%
22.60+1.50%
22.27-50.02%
44.55+83.25%
24.31—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

EV/EBITDA (Enterprise Value to EBITDA) of JVM Co is 9.05 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of JVM Co changed from 6.94 to 9.05, representing a 30.46% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) JVM Co since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s JVM Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — JVM Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — JVM Co